MPS Powered by Eureka

Current Pharmaceutical Biotechnology

ISSN: 1389-2010 (Print)
eISSN: 1873-4316 (Online)

Journal
Impact Factor :

2.2

Scopus
CiteScore:

5.6

Aims and Scope:Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:
  • DNA/protein engineering and processing
  • Synthetic biotechnology
  • Omics (genomics, proteomics, metabolomics and systems biology)
  • Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
  • Drug delivery and targeting
  • Nanobiotechnology
  • Molecular pharmaceutics and molecular pharmacology
  • Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
  • Pharmacokinetics and pharmacodynamics
  • Applied Microbiology
  • Bioinformatics (computational biopharmaceutics and modeling)
  • Environmental biotechnology
  • Regenerative medicine (stem cells, tissue engineering and biomaterials)
  • Translational immunology (cell therapies, antibody engineering, xenotransplantation)
  • Industrial bioprocesses for drug production and development
  • Biosafety
  • Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Editor-in-Chief:


Nikolaos E. LabrouDepartment of Biotechnology
Agricultural University of Athens
Athens
Greece

Indexed in:


Scopus, SCI Expanded, MEDLINE/PubMed... View all

Special Issues With Active Call for Papers

Submission closes on: Jun 20, 2026
The Impact of Fluorescence Imaging on Advancing Therapeutics and Regenerative Medicine

Advanced fluorescence and super-resolution imaging techniques have revolutionized therapeutics and regenerative medicine by enabling real-time visualization of drug delivery, RNA molecule localization, and intracellular interactions at the nanoscale. These imaging methods provide critical insights into cellular mechanisms, allowing precise tracking of therapeutic agents and optimization of delivery systems such as lipid nanoparticles. Moreover, they facilitate detailed monitoring of stem cell behavior, differentiation, and tissue integration, which are essential for advancing regenerative therapies. Non-invasive longitudinal imaging... see more

Submission closes on: Jun 19, 2026
Advanced Hybrid Solutions: Smart Bioinspired Materials and Platforms for Tissue Engineering and Regenerative Medicine

Bioinspired materials are redefining the landscape of regenerative medicine by mimicking the form and function of natural tissues. The integration of smart polymers and ceramic-based systems into hybrid platforms enables the design of biomaterials that are not only biocompatible and structurally supportive but also functionally dynamic. These advanced hybrid solutions are paving the way for personalized therapies in tissue engineering, drug delivery, and implantable devices. Leveraging emerging technologies such as 3D bioprinting, electrospinning, and nanoscale... see more

Submission closes on: Jun 11, 2026
Applications and Challenges of Nano-Biotechnology

This thematic issue aims to introduce readers to the fascinating intersection of nanotechnology and biology. It will bring together fundamental principles, materials, tools, and recent breakthroughs to help learners, researchers, and innovators understand how nanoscale science is revolutionizing biological and medical applications. Contributing authors will submit papers related to foundational principles, nano-bio interfaces, synthesis and fabrication methods, and advanced frontiers. It will cover a range of nanomaterials such as metal nanoparticles, liposomes, quantum dots, carbon-based... see more

Submission closes on: May 28, 2026
Process Development of Cell & Gene Therapy.

Cell and Gene Therapy is one of the most fundamental sectors of the biopharmaceutical industry. An efficient process development not only lowers the cost of CMC manufacturing but also best guarantees the quality of the production of biologics for newer Cell and Gene Therapy modalities. Here, we provide the Special Issue of Cell and Gene Therapy for the Current Pharmaceutical Biotechnology, to enlighten the future R&D of modalities and improve the efficiency of CMC manufacturing... see more

Submission closes on: Apr 10, 2026
25th Anniversary Special Issue.

Current Pharmaceutical Biotechnology (CPB) is celebrating its 25th anniversary with a special issue highlighting the journal’s growth and its pivotal contributions to innovation and knowledge in academia. Since its inaugural issue in 2000, CPB has fostered a multidisciplinary platform for emerging scholars to publish high-quality research in pharmaceutical biotechnology. Over the years, the journal has expanded its reach, increased its impact, and published influential contributions that have contributed to and shaped the field. This special... see more

Submission closes on: Dec 31, 2025
Latest Advancements in Biotherapeutics.

The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based approaches. We seek to unravel the complexities of personalized medicine, investigating the tailoring of treatments based on individual patient characteristics and the identification of biomarkers... see more

Submission closes on: Dec 31, 2025
Machine Learning and Artificial Intelligence for Medical Data Analysis and Human Information Analysis in Healthcare

The intersection of machine learning (ML) and artificial intelligence (AI) with the pharmaceutical industry is revolutionizing traditional paradigms in drug discovery and development. These technologies have introduced innovative approaches to analyzing complex datasets and predicting chemical properties, leading to more efficient identification and optimization of drug candidates. By employing sophisticated algorithms and computational models, AI and ML are enabling the pharmaceutical industry to address critical challenges, thus accelerating the arrival of novel therapies to patients.... see more